文章

GWOXI is deeply committed to the field of regenerative medicine, dedicating itself to the development of stem cell application technologies and the innovation of new stem cell drugs. Our mission is to address currently unmet medical needs.

By integrating its medical-grade stem cell manufacturing platform with numerous core technologies, GWOXI has accumulated hundreds of technical patents. This, combined with a strategic patent portfolio, has solidified the company's position in the cell therapy market.

Service and Quality Service and Quality Certificates To uphold the pharmaceutical-grade standards of quality control, GWOXI implements rigorous safeg

Founded in 2004, GWOXI established its presence in the Hsinchu Biomedical Science Park in 2011. The company's development journey, from new drug R&D and clinical trials to international exosome certifications, stands as a testament to the accumulation and transformation of its professional expertise in stem cell technology development.

GWOXI is centered on the development of stem cell technology. The company is planning a global strategy, enhancing its CDMO capabilities, and advancing the practical application of innovative solutions in stem cells and exosomes.

GWOXI has been deeply committed to stem cell R&D and clinical translation. The company has already applied for multiple compassionate use projects in partnership with medical institutions. Following the legislative approval of regenerative medicine implementation technology, GWOXI became even more proactive, collaborating with numerous medical centers and clinics. This allows the company to provide patients with emerging medical technology options and better meet their healthcare needs.

Testing Laboratory Testing Laboratory GTESTing® Laboratory GTESTing® Testing Laboratory: Quality Testing Services Laboratory Certification Nu

GWOXI stem cells not only integrate the regenerative medicine industry chain and establish PIC/S GMP-compliant cell therapy manufacturing facilities, but also further expand CDMO/ODM collaboration models to accelerate product development and market launch, enhancing market competitiveness.

GWOXI rigorously selects its cell sources and utilizes exclusive patented technology to efficiently obtain a greater quantity of high-quality stem cell exosomes. The company also conducts comprehensive testing on its exosome products to ensure their activity and purity.

Cooperation Cooperation International Collaboration Built upon a solid technical foundation, GWOXI works closely with its international partners. The company has already gained successful experience in exporting cell products overseas and has established strong partnerships with clients. To date, GWOXI has successfully implemented a cold chain shipping model that tracks the ambient temperature throughout the entire transportation process. Multiple batches have been delivered and met strict clinical accepta